Lukas Zell

Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach

D. Schuster, V. Temml, Jakub Kollár, 2022, Molecules.

Dopamine Receptor Ligand Selectivity—An In Silico/In Vitro Insight

D. Schuster, V. Temml, Lukas Zell, 2023, Biomedicines.

The NLRP3/eIF2 axis drives cell cycle progression in acute myeloid leukemia

Stephan M. Winkler, L. Pleyer, R. Greil, 2021, bioRxiv.

Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach

V. Temml, Lukas Zell, Bianka Siewert, 2023, J. Chem. Inf. Model..

Title: The NLRP3/eIF2 axis drives cell cycle progression in acute myeloid leukemia Short title: NLRP3 drives cell cycle progression in AML

Susanne, L. Pleyer, R. Greil, 2021 .